ll
|
Market Linked Notes — Autocallable with Contingent Coupon and Principal Return at Maturity Notes Linked to the Lowest Performing of the Common Stock of Bank of America Corporation, the Common Stock of Eli Lilly and Company, the Common Stock of Oracle Corporation and the Common Stock of ServiceNow, Inc. due September 8, 2031 |
Summary of Terms |
|
|
|
|
Company (Issuer) and Guarantor: |
GS Finance Corp. (issuer) and The Goldman Sachs Group, Inc. (guarantor) |
|
CUSIP: |
40058LNA4 |
Market Measures (each referred to as an “underlying stock,” and collectively as the “underlying stocks”): |
the common stock of Bank of America Corporation (current Bloomberg ticker: “BAC UN”), the common stock of Eli Lilly and Company (current Bloomberg ticker: “LLY UN”), the common stock of Oracle Corporation (current Bloomberg ticker: “ORCL UN”) and the common stock of ServiceNow, Inc. (current Bloomberg ticker: “NOW UN”) |
|
Tax consequences: |
See “Supplemental Discussion of U.S. Federal Income Tax Considerations” in the accompanying preliminary pricing supplement |
|
Underwriting discount: |
up to 3.325% of the face amount*; Wells Fargo Securities, LLC (“WFS”) is the agent for the distribution of the notes. WFS will receive the underwriting discount of up to 3.325% of the aggregate face amount of the notes sold. The agent may resell the notes to Wells Fargo Advisors (“WFA”) at the original issue price of the notes less a concession of 2.00% of the aggregate face amount of the notes. In addition to the selling concession received by WFA, WFS advises that WFA may also receive out of the underwriting discount a distribution expense fee of 0.075% for each $1,000 face amount of a note WFA sells. |
||
Pricing date: |
expected to be September 3, 2026 |
|
||
Issue date: |
expected to be September 9, 2026 |
|
||
Final calculation day: |
expected to be September 3, 2031 |
|
||
Stated maturity date: |
expected to be September 8, 2031 |
|
||
Starting price: |
with respect to an underlying stock, the stock closing price of such underlying stock on the pricing date |
|
||
Performance factor: |
with respect to an underlying stock on any calculation day, the quotient of (i) its stock closing price on such calculation day divided by its starting price (expressed as a percentage) |
|
||
Lowest performing underlying stock: |
for any calculation day, the underlying stock with the lowest performance factor on that calculation day |
|
* In addition, in respect of certain notes sold in this offering, GS&Co. may pay a fee of up to 0.30% of the aggregate face amount of the notes sold to selected securities dealers in consideration for marketing and other services in connection with the distribution of the notes to other securities dealers.
Any return on the notes will be limited to the sum of your contingent coupon payments, if any. You will not participate in any appreciation of any underlying stock. You should read the accompanying preliminary pricing supplement dated September 1, 2026, which we refer to herein as the accompanying preliminary pricing supplement, to better understand the terms and risks of your investment, including the credit risk of GS Finance Corp. and The Goldman Sachs Group, Inc. The notes are part of the Medium-Term Notes, Series F program of GS Finance Corp. and are fully and unconditionally guaranteed by The Goldman Sachs Group, Inc. This document should be read in conjunction with the following:
The estimated value of your notes at the time the terms of your notes are set on the pricing date is expected to be between $885 and $915 per $1,000 face amount. See the accompanying preliminary pricing supplement for a further discussion of the estimated value of your notes. |
|
Automatic call: |
If the stock closing price of the lowest performing underlying stock on any call date is greater than or equal to its starting price, the notes will be automatically called, and on the related call settlement date you will be entitled to receive a cash payment per note in U.S. dollars equal to the face amount plus a final contingent coupon payment. The notes will not be subject to automatic call until the September 2027 calculation day. |
|
||
Contingent coupon payment: |
Subject to the automatic call, on each contingent coupon payment date, for each $1,000 of the outstanding face amount, you will receive a contingent coupon payment equal to at least $9.167 (equivalent to a contingent coupon rate of at least approximately 11.00% per annum) (set on the pricing date) if, and only if, the stock closing price of the lowest performing underlying stock on the related calculation day is greater than or equal to its coupon threshold price. |
|
||
Coupon threshold price: |
with respect to an underlying stock, 70% of its starting price |
|
||
Call dates: |
monthly; the calculation days commencing in September 2027 ending in August 2031, inclusive |
|
||
Call settlement date: |
the contingent coupon payment date immediately following the applicable call date |
|
||
Calculation days: |
monthly, on the 3rd day of each month, commencing October 2026 and ending August 2031, and the final calculation day |
|
||
Contingent coupon payment dates: |
monthly, on the third business day following each calculation day; provided that the contingent coupon payment date with respect to the final calculation day will be the stated maturity date |
|
||
Maturity payment amount (for each $1,000 face amount of your notes): |
If the notes are not automatically called prior to the stated maturity date, you will be entitled to receive on the stated maturity date a cash payment per note in U.S. dollars equal to the maturity payment amount (in addition to the final contingent coupon payment, if any). The “maturity payment amount” per note will equal $1,000. |
|
||
The notes have more complex features than conventional debt securities and involve risks not associated with conventional debt securities. See “Risk Factors” in this term sheet and in the accompanying preliminary pricing supplement. This document does not provide all of the information that an investor should consider prior to making an investment decision. You should not invest in the notes without reading the accompanying preliminary pricing supplement and related documents for a more detailed description of the underlying stocks, the terms of the notes and certain risks.
